Karyopharm Therapeutics Inc (KPTI) — Long-term Investment Intensity
Karyopharm Therapeutics Inc (KPTI) has a Long-term Investment Intensity of 0.8% as of September 2021. Long-term investments of $2.00 Million represent 0.8% of total assets of $254.09 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check total reinvestment intensity of Karyopharm Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Karyopharm Therapeutics Inc Long-term Investment Intensity (2014–2020)
This chart shows how Karyopharm Therapeutics Inc's Long-term Investment Intensity has evolved across 7 annual periods from 2014 to 2020. As of September 2021, the intensity stands at 0.8%, reflecting long-term investments of $2.00 Million against total assets of $254.09 Million USD. Explore Karyopharm Therapeutics Inc (KPTI) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Karyopharm Therapeutics Inc (2014–2020)
The table below presents the year-by-year Long-term Investment Intensity for Karyopharm Therapeutics Inc from 2014 to 2020, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Karyopharm Therapeutics Inc (KPTI) total market value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2020 | 7.7% | $24.21 Million | $313.05 Million | ▲ +7.1 pp |
| 2019 | 0.7% | $2.02 Million | $294.96 Million | ▲ +0.1 pp |
| 2018 | 0.6% | $2.00 Million | $341.19 Million | ▼ -15.7 pp |
| 2017 | 16.3% | $29.40 Million | $180.29 Million | ▼ -8.9 pp |
| 2016 | 25.2% | $45.43 Million | $180.38 Million | ▲ +9.5 pp |
| 2015 | 15.7% | $33.88 Million | $215.44 Million | ▲ +11.8 pp |
| 2014 | 3.9% | $8.66 Million | $220.34 Million | — |